Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galam is a leading global manufacturer of sugar-based products and functional ingredients, specializing in the development of high-quality sweeteners and prebiotics. The company is best known for its flagship brand, GOFOS, a short-chain fructo-oligosaccharide (sc-FOS) produced from beet sugar through a proprietary enzymatic process. These prebiotic fibers are designed to promote the growth of beneficial gut bacteria and are used extensively in the food, beverage, and dietary supplement industries. Headquartered in Israel, Galam operates advanced manufacturing facilities and maintains a global distribution network serving the pharmaceutical and nutraceutical sectors. The company also provides a range of crystalline fructose, glucose syrups, and starches for diverse industrial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Galam Group.